Frontlight ResearchEarly access
Active, not recruitingNo phase
Iliac Stent-Grafts in TASC C-D Lesions
Key facts
- Who runs it
- Samsun University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 52 people, planned
- Started
- 1 Jan 2024
- Ended
- 30 Aug 2025
- Type of study
- Observational
- Record updated
- 20 July 2025
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients with TASC C-D iliac artery lesions
- Procedures done within last 5 years in the same clinic
- Aged between 18-85 years
- Not eligible for open surgery or refused it
Who cannot take part
- Age <18 or >85
- TASC A-B lesions
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the midterm outcomes of patients with advanced aortoiliac artery narrowing (TASC C-D lesions) who were treated with covered iliac stent-grafts instead of open surgery. These patients were either too high-risk for surgery or refused it. Medical records from the past five years at a single cardiovascular surgery center in Turkey were reviewed retrospectively. The research focuses on the success rate of the procedure, complications, vessel patency, and the need for additional treatments. The results may help guide treatment decisions in similar high-risk patients who are not candidates for open vascular surgery.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Endovascular Treatment of TASC II C-D Iliac Artery Lesions Using Covered Stents: A Retrospective Cohort Study
- Record updated
- 20 July 2025